Rothschild Investment LLC’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.82K Sell
463
-64
-12% -$715 ﹤0.01% 2288
2026
Q1
$6.27K Buy
527
+373
+242% +$3.82K ﹤0.01% 1942
2025
Q4
$1.53K Sell
154
-67
-30% -$640 ﹤0.01% 2495
2025
Q3
$1.98K Sell
221
-14
-6% -$130 ﹤0.01% 2239
2025
Q2
$2.22K Buy
235
+90
+62% +$794 ﹤0.01% 2004
2025
Q1
$1.57K Buy
145
+70
+93% +$704 ﹤0.01% 2052
2024
Q4
$714 Sell
75
-35
-32% -$354 ﹤0.01% 2397
2024
Q3
$1.24K Buy
110
+65
+144% +$691 ﹤0.01% 2012
2024
Q2
$450 Buy
45
+35
+350% +$356 ﹤0.01% 2084
2024
Q1
$115 Buy
+10
New +$85 ﹤0.01% 2134

Other funds holding AHCO

Rothschild Investment LLC's AHCO Position: Q2 2026 in Review

Rothschild Investment LLC reduced its AdaptHealth (AHCO) stake by 12% in Q2 2026, selling an estimated $715 and leaving 463 shares worth $4.82K. The position accounts for ﹤0.01% of the portfolio, ranked #2288.

Rothschild Investment LLC first reported a position in AHCO in Q1 2024 and has held it in 10 quarters since. The position peaked at $6.27K in Q1 2026. 238 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • Rothschild Investment LLC held 463 shares of AdaptHealth worth $4.82K as of Q2 2026.
  • Rothschild Investment LLC sold 64 AdaptHealth shares in Q2 2026, an estimated $715.
  • AdaptHealth made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2288 holding.
  • Rothschild Investment LLC first reported a position in AdaptHealth in Q1 2024 and has held it in 10 quarters since.
  • Rothschild Investment LLC's AdaptHealth position peaked at $6.27K in Q1 2026.
  • 238 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.